NCT02228785View on ClinicalTrials.gov

A Study of the Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 31, 1994

Primary Completion Date

October 31, 1994

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

G17DT

Sponsors
All Listed Sponsors
lead

Cancer Advances Inc.

INDUSTRY

NCT02228785 - A Study of the Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter